Endurant Capital Management LP - Q3 2023 holdings

$111 Million is the total value of Endurant Capital Management LP's 43 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 120.6% .

 Value Shares↓ Weighting
BMRN BuyBIOMARIN PHARMACEUTICAL INC$15,888,177
+320.4%
179,568
+311.8%
14.27%
+332.4%
TMO NewTHERMO FISHER SCIENTIFIC INC$7,009,94813,849
+100.0%
6.30%
BRKR BuyBRUKER CORP$6,932,495
+515.1%
111,276
+629.9%
6.23%
+532.7%
AZN BuyASTRAZENECA PLCsponsored adr$6,531,188
+50.1%
96,444
+58.6%
5.87%
+54.4%
ANTM BuyELEVANCE HEALTH INC$5,878,605
+134.8%
13,501
+139.5%
5.28%
+141.5%
AVTR NewAVANTOR INC$4,782,567226,877
+100.0%
4.30%
MRK SellMERCK & CO INC$4,569,333
-19.7%
44,384
-10.0%
4.10%
-17.4%
ARGX BuyARGENX SEsponsored adr$4,477,766
+347.9%
9,108
+255.1%
4.02%
+360.6%
CNMD NewCONMED CORP$4,234,08641,984
+100.0%
3.80%
COO NewCOOPER COS INC$3,667,60911,533
+100.0%
3.29%
HUM NewHUMANA INC$3,203,2486,584
+100.0%
2.88%
TXG New10X GENOMICS INC$2,930,56571,044
+100.0%
2.63%
SBRA NewSABRA HEALTH CARE REIT INC$2,840,860203,792
+100.0%
2.55%
OHI NewOMEGA HEALTHCARE INVS INC$2,655,12180,070
+100.0%
2.38%
BSX SellBOSTON SCIENTIFIC CORP$2,528,750
-23.3%
47,893
-21.5%
2.27%
-21.1%
KIDS BuyORTHOPEDIATRICS CORP$2,251,648
+378.1%
70,364
+555.1%
2.02%
+392.0%
ABC NewCENCORA INC$2,088,73211,606
+100.0%
1.88%
SYK NewSTRYKER CORPORATION$2,062,3697,547
+100.0%
1.85%
INSM  INSMED INC$2,006,643
+19.7%
79,4710.0%1.80%
+23.1%
ZBH NewZIMMER BIOMET HOLDINGS INC$1,961,49317,479
+100.0%
1.76%
NewQUIDELORTHO CORP$1,953,60126,747
+100.0%
1.76%
DXCM NewDEXCOM INC$1,930,75020,694
+100.0%
1.73%
THC SellTENET HEALTHCARE CORP$1,788,979
-62.1%
27,151
-53.2%
1.61%
-61.0%
ABT NewABBOTT LABS$1,747,17418,040
+100.0%
1.57%
CI SellTHE CIGNA GROUP$1,740,164
-76.0%
6,083
-76.4%
1.56%
-75.3%
PODD NewINSULET CORP$1,415,9528,878
+100.0%
1.27%
ETNB Buy89BIO INC$1,268,442
+128.6%
82,153
+180.6%
1.14%
+135.3%
HOLX NewHOLOGIC INC$1,231,85017,750
+100.0%
1.11%
OCUL SellOCULAR THERAPEUTIX INC$1,110,640
-41.6%
353,707
-4.0%
1.00%
-39.9%
BRKS NewAZENTA INC$974,79019,422
+100.0%
0.88%
TARS NewTARSUS PHARMACEUTICALS INC$846,72347,649
+100.0%
0.76%
AHCO NewADAPTHEALTH CORP$818,42789,937
+100.0%
0.74%
AXSM NewAXSOME THERAPEUTICS INC$786,54211,254
+100.0%
0.71%
IQV SellIQVIA HLDGS INC$776,376
-82.0%
3,946
-79.4%
0.70%
-81.5%
BLUE SellBLUEBIRD BIO INC$765,426
-17.3%
251,785
-10.5%
0.69%
-15.0%
OLMA BuyOLEMA PHARMACEUTICALS INC$723,377
+99.4%
58,573
+45.8%
0.65%
+105.0%
NewVENTYX BIOSCIENCES INC$641,04618,458
+100.0%
0.58%
NewARCELLX INC$507,98914,158
+100.0%
0.46%
GDRX NewGOODRX HLDGS INC$491,44387,290
+100.0%
0.44%
SELB SellSELECTA BIOSCIENCES INC$480,513
-37.5%
453,314
-33.9%
0.43%
-35.6%
TLT NewISHARES TR20 yr tr bd etf$301,5463,400
+100.0%
0.27%
NVST NewENVISTA HOLDINGS CORPORATION$300,74210,787
+100.0%
0.27%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$243,316
-68.0%
311,944
-62.0%
0.22%
-67.0%
VKTX ExitVIKING THERAPEUTICS INC$0-20,754
-100.0%
-0.29%
BTAI ExitBIOXCEL THERAPEUTICS INCcall$0-57,100
-100.0%
-0.33%
MASI ExitMASIMO CORP$0-2,850
-100.0%
-0.41%
ACHC ExitACADIA HEALTHCARE COMPANY IN$0-9,153
-100.0%
-0.64%
ZTS ExitZOETIS INCcl a$0-7,643
-100.0%
-1.15%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDcall$0-175,000
-100.0%
-1.15%
VTR ExitVENTAS INC$0-41,575
-100.0%
-1.72%
EHC ExitENCOMPASS HEALTH CORP$0-32,710
-100.0%
-1.93%
MDT ExitMEDTRONIC PLC$0-27,181
-100.0%
-2.09%
QGEN ExitQIAGEN NV$0-62,708
-100.0%
-2.46%
CAH ExitCARDINAL HEALTH INC$0-31,696
-100.0%
-2.62%
BDX ExitBECTON DICKINSON & CO$0-13,360
-100.0%
-3.08%
A ExitAGILENT TECHNOLOGIES INC$0-45,762
-100.0%
-4.80%
LH ExitLABORATORY CORP AMER HLDGS$0-32,569
-100.0%
-6.86%
BMRN ExitBIOMARIN PHARMACEUTICAL INCcall$0-93,600
-100.0%
-7.08%
SPY ExitSPDR S&P 500 ETF TRput$0-6,100
-100.0%
-23.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
INVACARE HOLDINGS CorpSeptember 08, 202339,488,56984.9%
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21
SC 13G/A2023-02-14

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings